Tada wrote: "I have heard that one patient started the trial with an eGFR of 18 and about 6 months later that patients eGFR was 34."

FYI from Tada who replied to my PM regarding the above statement: "I heard this info around the time of the AGM or the broker meeting in Calgary in January. I can't remember the exact time. I don't think it could possibly be insider info as in either case above it was said in a group situation as I was not privy to any one on one conversations at the AGM and simply heard regurgitations from the broker meeting."